$3.69
Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
Liminatus Pharma Reports Reverse Stock Split
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
Overview
52-week range
$3.42
$142
0% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
-2.2%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.03 | — | — | — | — | financials |
| Fri May 15, 2026 | Mar/2026 | $-0.03 | — | — | — | -2.2% | earnings |
| Fri Oct 3, 2025 | Jun/2025 | $-0.05 | — | — | — | — | earnings |
| Mon Jun 30, 2025 | Jun 2025 | — | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.03 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.05 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-2.47 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-1M | — | — | $-701,170 | $-1M | — | — | $-543,147 |
| Net income | $-1M | $-1M | — | $-2M | $113,287 | $-327,526 | — | $-601,372 |
| EPS (diluted) | $-0.03 | — | — | $-0.07 | — | — | — | $-0.03 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3M | — | $337,655 | $724,502 | $1M | — | $56,319 | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $3M | — | $500,574 | $1M | $2M | — | $5M | — |
| Total assets | $3M | — | $512,795 | $1M | $2M | — | $5M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | — | $10M | $3M | $11M | $1,060 | $25M | — |
| Total equity | $300,612 | $-132,596 | $-10M | $-2M | $-9M | $-20M | $-19M | $-19M |
Implied volatility — last 90 days
No IV snapshots yet for LIMN.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.